Advertisement

Expert Point of View: Ana Maria Lopez, MD


Advertisement
Get Permission

Ana Maria Lopez, MD, Professor and Vice Chair of Medical Oncology and Chief of Cancer Services for the Sidney Kimmel Cancer Center, Jefferson Health New Jersey, commented on Dr. Reid’s presentation.

“Dr. Reid presented a report about a robust cancer program that addresses the needs of rural populations, urban-at-risk populations, and culturally and linguistically diverse populations; the program also seeks to collect comprehensive data to assess outcomes. Dr. Reid noted that the documented drop in cancer screening [during the COVID-19 pandemic] will have negative implications on outcomes,” noted Dr. Lopez.

Ana Maria Lopez, MD

Ana Maria Lopez, MD

Stressing the need for a collaborative approach, Dr. Lopez concluded: “Part of our job now is to ‘catch up’ on screening and to continue to work on facilitating access to care. This is best done by partnering—for example, with primary care teams.

DISCLOSURE: Dr. Lopez reported no conflicts of interest.

 


Related Articles

Fallout From COVID-19: Decline in Cancer Screening and Increase in Cancer-Related Deaths

Various studies at institutions in the United States and abroad have shown a substantial decline in cancer screening rates during the COVID-19 pandemic, suggesting that fewer cancers will be detected by screening and when they do manifest, they will be at more advanced stages. Indeed,...

Advertisement

Advertisement




Advertisement